Last update 01 Nov 2024
CISTIM

CISTIM

Private Company|
2007|
Belgium
|
10-50
|
www.cistim.be

Overview

Tags

Infectious Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
SARS-CoV-2 3CLpro(SARS-CoV-2-3C-like-proteinase)1
DENV NS3 x DENV NS4B1

Related

2
Drugs associated with CISTIM
ALG-097111
Target
SARS-CoV-2 3CLpro
Mechanism
SARS-CoV 3CLpro inhibitors
Active Org.
Aligos Therapeutics, Inc.Aligos Therapeutics, Inc. [+3]
Originator Org.
Rega Institute for Medical Research [+2]
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Mosnodenvir
Target
DENV NS3 x DENV NS4B
Mechanism
DENV NS3 inhibitors [+1]
Active Org.
Janssen-Cilag SAS [+2]
Originator Org.
Janssen Research & Development LLC
Active Indication
Dengue
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with CISTIM
Login to view more data
0 Patents (Medical) associated with CISTIM
Login to view more data
100 Deals associated with CISTIM
Login to view more data
100 Translational Medicine associated with CISTIM
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Mosnodenvir
 ( DENV NS3 x DENV NS4B )		Dengue
More
Preclinical
ALG-097111
 ( SARS-CoV-2 3CLpro )		COVID-19
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free